Bellevue Group’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.72M Buy
37,177
+11,611
+45% +$537K 0.04% 97
2025
Q1
$1.56M Sell
25,566
-12,547
-33% -$765K 0.03% 102
2024
Q4
$2.16M Buy
38,113
+1,288
+3% +$72.8K 0.04% 107
2024
Q3
$1.91M Buy
+36,825
New +$1.91M 0.03% 106
2024
Q2
Sell
-23,436
Closed -$1.27M 169
2024
Q1
$1.27M Buy
+23,436
New +$1.27M 0.02% 114
2023
Q2
Sell
-1,496
Closed -$104K 157
2023
Q1
$104K Sell
1,496
-48,759
-97% -$3.38M ﹤0.01% 150
2022
Q4
$3.62M Buy
50,255
+43,193
+612% +$3.11M 0.05% 117
2022
Q3
$502K Sell
7,062
-17,845
-72% -$1.27M 0.01% 149
2022
Q2
$1.92M Sell
24,907
-603,221
-96% -$46.5M 0.03% 129
2022
Q1
$45.9M Sell
628,128
-431,219
-41% -$31.5M 0.53% 60
2021
Q4
$66.1M Sell
1,059,347
-243,587
-19% -$15.2M 0.68% 51
2021
Q3
$77.1M Sell
1,302,934
-160,498
-11% -$9.5M 0.78% 43
2021
Q2
$97.8M Sell
1,463,432
-621,720
-30% -$41.5M 0.95% 32
2021
Q1
$132M Buy
2,085,152
+280,680
+16% +$17.7M 1.39% 20
2020
Q4
$112M Buy
1,804,472
+158,560
+10% +$9.84M 1.28% 24
2020
Q3
$99.2M Buy
1,645,912
+33,800
+2% +$2.04M 1.37% 18
2020
Q2
$94.8M Buy
1,612,112
+406,640
+34% +$23.9M 1.34% 18
2020
Q1
$67.2M Sell
1,205,472
-883,770
-42% -$49.3M 1.3% 19
2019
Q4
$134M Buy
2,089,242
+1,152,233
+123% +$74M 2.13% 12
2019
Q3
$47.5M Buy
937,009
+81,400
+10% +$4.13M 0.88% 33
2019
Q2
$38.8M Buy
855,609
+159,785
+23% +$7.25M 0.66% 39
2019
Q1
$33.2M Buy
695,824
+209,000
+43% +$9.97M 1.83% 12
2018
Q4
$25.3M Buy
486,824
+145,095
+42% +$7.54M 1.66% 15
2018
Q3
$21.2M Buy
341,729
+80,880
+31% +$5.02M 1.35% 21
2018
Q2
$14.4M Buy
260,849
+220,849
+552% +$12.2M 1.23% 27
2018
Q1
$2.53M Buy
+40,000
New +$2.53M 0.25% 71
2017
Q2
Sell
-23,000
Closed -$1.25M 133
2017
Q1
$1.25M Hold
23,000
0.17% 92
2016
Q4
$1.34M Hold
23,000
0.28% 78
2016
Q3
$1.24M Hold
23,000
0.22% 89
2016
Q2
$1.69M Sell
23,000
-37,000
-62% -$2.72M 0.32% 78
2016
Q1
$3.83M Buy
+60,000
New +$3.83M 0.7% 49